Critical Update and Emerging Trends in Imatinib Treatment for Gastrointestinal Stromal Tumor

2007 ◽  
Vol 2 (1) ◽  
pp. 43-48 ◽  
Author(s):  
Ugo De Giorgi ◽  
Alberto Pupi ◽  
Gina Turrisi ◽  
Iolanda Montenora ◽  
Stefano Morini ◽  
...  
2008 ◽  
Vol 206 (2) ◽  
pp. 386-387 ◽  
Author(s):  
Massimo Chiarugi ◽  
Christian Galatioto ◽  
Piero V. Lippolis ◽  
Massimo Seccia

2019 ◽  
Vol 12 (1) ◽  
pp. 183-191 ◽  
Author(s):  
Patrick Schöffski ◽  
Raf Sciot ◽  
Maria Debiec-Rychter ◽  
Johan Van Ongeval ◽  
André D'Hoore ◽  
...  

We report a very uncommon case of a primary, non-metastatic gastrointestinal stromal tumor (GIST) arising in the prostate gland in a 60-year-old patient. The morphology and immunohistochemical profile of the disease resembled GIST of gastrointestinal origin, and the molecular driver of this malignancy was a double mutation in exons 11 and 13 of the KIT gene. The tumor was proliferating slowly, did respond to neoadjuvant therapy with the KIT-inhibiting agent imatinib and was cured by radical, retro-pubic prostatectomy followed by adjuvant imatinib treatment. We postulate that primary GIST tumors of the prostate can arise from prostatic interstitial cells, which are the pacemakers of smooth muscle contractility in the gland, and possibly share a common precursor with typical GIST and the interstitial cells of Cajal in the gastrointestinal tract.


2016 ◽  
Vol 14 (1) ◽  
Author(s):  
Kennoki Kyo ◽  
Masaki Azuma ◽  
Kazuya Okamoto ◽  
Motohiro Nishiyama ◽  
Takahiro Shimamura ◽  
...  

Esophagus ◽  
2010 ◽  
Vol 7 (1) ◽  
pp. 65-69 ◽  
Author(s):  
Hiroki Sato ◽  
Tatsuo Kanda ◽  
Seiichi Hirota ◽  
Takeo Bamba ◽  
Kaoru Sakamoto ◽  
...  

Medicine ◽  
2017 ◽  
Vol 96 (49) ◽  
pp. e9031 ◽  
Author(s):  
Minsun Jung ◽  
Sung-Hye Park ◽  
Yoon Kyung Jeon ◽  
Jae-Kyung Won ◽  
Han-Kwang Yang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document